PHARMACEUTICAL PRODUCTS FORMULATIONS

Brand Owner (click to sort) Address Description
AMPHOCIL LIPOSOME TECHNOLOGY, INC. 1150 HAMILTON COURT MENLO PARK CA 94025 pharmaceutical products and formulations for the treatment of infections;AMPHOCIL;
AMPHOTEC KADMON PHARMACEUTICALS 119 Commonwealth Drive Warrendale PA 15086 pharmaceutical products and formulations for treatment of infections;
CAELYX SEQUUS PHARMACEUTICALS, INC. 960 Hamilton Court Menlo Park CA 94025 pharmaceutical products and formulations for the treatment of cancer;
DOX-SL LIPOSOME TECHNOLOGY, INC. 1150 HAMILTON COURT MENLO PARK CA 94025 pharmaceutical products and formulations for the treatment of cancer;
DOXIL BAXTER INTERNATIONAL INC. One Baxter Parkway Deerfield IL 60015 pharmaceutical products and formulations for the treatment of cancer;
LTI LIPOSOME TECHNOLOGY, INC. 1150 HAMILTON COURT MENLO PARK CA 94025 PHARMACEUTICAL PRODUCTS AND FORMULATIONS;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. Parenteral pharmaceutical formulations containing an echinocandin antifungal compound and an aqueous solvent are provided, wherein the formulation includes ethanol, for example about 20% w/v ethanol. The parenteral pharmaceutical formulation may further include one or more additives, such as a stabilizing agent, buffer or tonicity agent. The parenteral pharmaceutical formulations are useful in extending the shelf life and improving the solubility of the echinocandin antifungal compound.